Physician profile
Adena Shahinian
NPI 1457708182
$6,431.98
in general payments reported to CMS, 2019-2025
47 companies · $1,978 in 2025
The $1,978 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $81.60 · 2021: $305 · 2022: $620 · 2023: $1,695 · 2024: $1,366 · 2025: $1,978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,963 · Education: $76.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,962.73 |
| Education | $76.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,033.21 | 2023-2025 | Ubrelvy, Duopa, Qulipta |
| Ucb, INC. | $856.81 | 2022-2025 | Fintepla, Briviact, Nayzilam |
| Teva Pharmaceuticals USA, INC. | $386.46 | 2023-2025 | Austedo Xr, Austedo Xr, Austedo |
| Sumitomo Pharma America, INC. | $366.51 | 2023-2024 | Aptiom |
| Lundbeck LLC | $333.50 | 2019-2025 | Vyepti |
| Sk Life Science, INC. | $320.60 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $230.62 | 2022 | |
| Livanova USA, INC. | $199.45 | 2022-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Amneal Pharmaceuticals LLC | $187.71 | 2023-2025 | Crexont, Rytary |
| Novartis Pharmaceuticals Corporation | $185.20 | 2019-2025 | |
| Lilly USA, LLC | $169.72 | 2022-2025 | Amyvid, Kisunla, Emgality |
| Neurelis, INC. | $159.34 | 2021-2025 | Valtoco |
| Pfizer INC. | $156.81 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $149.31 | 2019-2024 | Ultomiris |
| Celgene Corporation | $148.14 | 2020-2024 | Zeposia |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adena Shahinian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.